• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全外显子组测序揭示中国人群原发性心肌病的遗传图谱及基因型-表型关联。

Whole exome sequence reveals genetic profiles of primary cardiomyopathy and genotype-phenotype association in Chinese population.

作者信息

Liu Rui-Lin, Yang Yi-Feng, Gong Ke, Wang Lei, Yao Yao, Xie Li

机构信息

Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Central South University, Changsha, China.

The Clinical Center for Gene Diagnosis and Therapy, The Second Xiangya Hospital of Central South University, Central South University, Changsha, China.

出版信息

BMC Genomics. 2025 Feb 17;26(1):150. doi: 10.1186/s12864-025-11323-4.

DOI:10.1186/s12864-025-11323-4
PMID:39962380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11834636/
Abstract

BACKGROUND

Primary cardiomyopathies are major causes of heart failure, placing a substantial burden on both individuals and society. Revealing its genetic profiles can lead to a better understanding of the mechanism and is critical for disease prevention and treatment.

METHOD

Primary cardiomyopathy patients were enrolled and whole exome sequence was conducted to analyze their genetic profiles. Retrospective clinical information extraction and analysis of sequence data were implemented.

RESULTS

A total of 77 primary cardiomyopathy patients were enrolled, comprising 65 patients with dilated cardiomyopathy (DCM) and 12 with hypertrophic cardiomyopathy (HCM). Among the DCM patients, 13 variants classified as pathogenic (P) or likely pathogenic (LP) were identified in 12 patients (18.46%), predominantly in genes associated with the nuclear envelope and sarcomere. Among HCM patients, 6 P/LP variants were discovered in 6 (50%) patients. Taking variants of uncertain significance (VUS) into consideration, an analysis of the association between the number of variants carried by patients and their clinical characteristics revealed that DCM patients with more than one variant had a higher proportion of hyperuricemia.

CONCLUSIONS

We map a comprehensive profile of primary cardiomyopathy in Chinese population and, for the first time, identify a possible association between hyperuricemia and the number of genetic variants carried by DCM patients.

摘要

背景

原发性心肌病是心力衰竭的主要原因,给个人和社会都带来了沉重负担。揭示其基因图谱有助于更好地理解发病机制,对疾病的预防和治疗至关重要。

方法

招募原发性心肌病患者,进行全外显子组测序以分析其基因图谱。实施回顾性临床信息提取和序列数据分析。

结果

共招募了77例原发性心肌病患者,其中包括65例扩张型心肌病(DCM)患者和12例肥厚型心肌病(HCM)患者。在DCM患者中,12例患者(18.46%)鉴定出13个分类为致病(P)或可能致病(LP)的变异,主要存在于与核膜和肌节相关的基因中。在HCM患者中,6例(50%)患者发现了6个P/LP变异。考虑到意义未明的变异(VUS),对患者携带的变异数量与其临床特征之间的关联分析显示,携带多个变异的DCM患者高尿酸血症的比例更高。

结论

我们绘制了中国人群原发性心肌病的综合图谱,并首次确定高尿酸血症与DCM患者携带的基因变异数量之间可能存在关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/11834636/16a0ae6578b9/12864_2025_11323_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/11834636/e6e4fc634a10/12864_2025_11323_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/11834636/d05408071b3b/12864_2025_11323_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/11834636/16a0ae6578b9/12864_2025_11323_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/11834636/e6e4fc634a10/12864_2025_11323_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/11834636/d05408071b3b/12864_2025_11323_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/11834636/16a0ae6578b9/12864_2025_11323_Fig3_HTML.jpg

相似文献

1
Whole exome sequence reveals genetic profiles of primary cardiomyopathy and genotype-phenotype association in Chinese population.全外显子组测序揭示中国人群原发性心肌病的遗传图谱及基因型-表型关联。
BMC Genomics. 2025 Feb 17;26(1):150. doi: 10.1186/s12864-025-11323-4.
2
Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.临床外显子组测序揭示了肥厚型心肌病遗传异质性和基因型-表型相关性的广泛多样性。
Int J Cardiol. 2024 Sep 15;411:132273. doi: 10.1016/j.ijcard.2024.132273. Epub 2024 Jun 14.
3
Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing.采用全外显子组测序技术对中国人群接受心脏移植的扩张型心肌病患者进行遗传特征分析。
J Transl Med. 2023 Jul 17;21(1):476. doi: 10.1186/s12967-023-04282-5.
4
Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.在卡塔尔对心肌病进行的基因评估中,发现了肌节基因变异的致病性富集,以及阿拉伯人中可能存在的致病变异体突变。
Mol Genet Genomic Med. 2021 Jul;9(7):e1709. doi: 10.1002/mgg3.1709. Epub 2021 Jun 17.
5
Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population.普通人群中与遗传性心肌病相关的致病性和可能致病性变异体的流行率和疾病表达。
Circ Genom Precis Med. 2022 Dec;15(6):e003704. doi: 10.1161/CIRCGEN.122.003704. Epub 2022 Oct 20.
6
Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3.BAG3中扩张型和肥厚型心肌病的双向风险调节因子及修饰变异体
JAMA Cardiol. 2024 Dec 1;9(12):1124-1133. doi: 10.1001/jamacardio.2024.3547.
7
Coverage and diagnostic yield of Whole Exome Sequencing for the Evaluation of Cases with Dilated and Hypertrophic Cardiomyopathy.扩张型和肥厚型心肌病病例评估中全外显子组测序的覆盖度和诊断收益。
Sci Rep. 2018 Jul 18;8(1):10846. doi: 10.1038/s41598-018-29263-3.
8
New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants.新的基于人群的外显子组数据对先前与心肌病相关的遗传变异的致病性提出了质疑。
Eur J Hum Genet. 2013 Sep;21(9):918-28. doi: 10.1038/ejhg.2012.283. Epub 2013 Jan 9.
9
Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.扩张型心肌病全外显子组测序的效用的前瞻性评估。
J Am Heart Assoc. 2020 Jan 21;9(2):e013346. doi: 10.1161/JAHA.119.013346. Epub 2020 Jan 14.
10
Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy.基因组背景在人类扩张型心肌病和肥厚型心肌病之间存在差异。
J Am Heart Assoc. 2021 Apr 6;10(7):e019944. doi: 10.1161/JAHA.120.019944. Epub 2021 Mar 25.

本文引用的文献

1
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.心肌病相关基因中罕见变异的外显率:一种用于估计次要发现外显率的横断面方法。
Am J Hum Genet. 2023 Sep 7;110(9):1482-1495. doi: 10.1016/j.ajhg.2023.08.003. Epub 2023 Aug 30.
2
A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients.多例心律失常性右室心肌病患者桥粒相关基因变异再分类与临床结局的系统分析。
J Cardiovasc Transl Res. 2023 Dec;16(6):1276-1286. doi: 10.1007/s12265-023-10403-8. Epub 2023 Jul 7.
3
Molecular autopsy: Twenty years of post-mortem diagnosis in sudden cardiac death.
分子尸检:心脏性猝死的二十年尸检诊断
Front Med (Lausanne). 2023 Feb 10;10:1118585. doi: 10.3389/fmed.2023.1118585. eCollection 2023.
4
A novel likely pathogenic variant in the FBXO32 gene associated with dilated cardiomyopathy according to whole‑exome sequencing.全外显子测序提示 FBXO32 基因中的一种新的可能致病性变异与扩张型心肌病相关。
BMC Med Genomics. 2022 Nov 7;15(1):234. doi: 10.1186/s12920-022-01388-5.
5
Identification of a Novel de Novo Variant in the CASZ1 Causing a Rare Type of Dilated Cardiomyopathy.鉴定导致罕见扩张型心肌病的 CASZ1 基因中的新型从头变异。
Int J Mol Sci. 2022 Oct 20;23(20):12506. doi: 10.3390/ijms232012506.
6
Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction.降低血尿酸水平可能改善伴左室射血分数保留的心力衰竭患者的预后。
J Am Heart Assoc. 2022 Oct 4;11(19):e026301. doi: 10.1161/JAHA.122.026301. Epub 2022 Sep 21.
7
Whole-Exome Sequencing Identifies a Novel Variant (c.1538T > C) of in Arrhythmogenic Right Ventricular Cardiomyopathy.全外显子组测序鉴定出致心律失常性右室心肌病中一种新的(c.1538T > C)变异。
Front Cardiovasc Med. 2022 Feb 22;9:843837. doi: 10.3389/fcvm.2022.843837. eCollection 2022.
8
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation.反义疗法减轻小鼠磷蛋白 p.(Arg14del)心肌病并逆转蛋白聚集。
Int J Mol Sci. 2022 Feb 22;23(5):2427. doi: 10.3390/ijms23052427.
9
Modern genomic techniques in the identification of genetic causes of cardiomyopathy.现代基因组技术在心肌病遗传病因鉴定中的应用。
Heart. 2022 Nov 10;108(23):1843-1850. doi: 10.1136/heartjnl-2021-320424.
10
Hypertrophic Cardiomyopathy: New Concepts and Therapies.肥厚型心肌病:新概念与治疗方法。
Annu Rev Med. 2022 Jan 27;73:363-375. doi: 10.1146/annurev-med-042220-021539.